Summary
Boston Scientific Corporation (BSX) filed an 8-K on April 24, 2019, to report its financial results for the first quarter ended March 31, 2019. The filing itself is primarily an announcement of the earnings release, which is included as an exhibit. Investors should refer to the press release (Exhibit 99.1) for detailed financial performance, including revenue, earnings per share, and segment performance. While the 8-K doesn't provide the specific numbers, it signals that the company has disclosed its Q1 2019 performance. Key metrics and forward-looking guidance, if provided in the press release, will be crucial for understanding the company's current trajectory and future outlook. Investors should review the earnings release for critical insights into operational performance and any strategic updates.
Key Highlights
- 1Boston Scientific reported its first-quarter 2019 financial results on April 24, 2019.
- 2The 8-K filing primarily serves to furnish the company's official earnings press release.
- 3Investors are directed to the press release (Exhibit 99.1) for detailed financial performance data.
- 4The filing indicates the company's financial reporting for the period ending March 31, 2019.
- 5Information furnished under Item 2.02 is not considered 'filed' for purposes of Section 18 of the Exchange Act.